Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development and selection of Valpha l4i NKT cells.

H R MacDonald1, M P Mycko

  • 1Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland. hughrobson.macdonald@isrec.unil.ch

Current Topics in Microbiology and Immunology
|June 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of human IL-10-producing neutrophils by LPS-stimulated Treg cells and IL-10.

Mucosal immunology·2015
Same author

DL4-mediated Notch signaling is required for the development of fetal αβ and γδ T cells.

European journal of immunology·2013
Same author

"Au pair".

Canadian Medical Association journal·2010
Same author

Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

The tumor suppressor p16Ink4a regulates T lymphocyte survival.

Oncogene·2006
Same author

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Neurology·2005

Invariant natural killer T (iNKT) cells are a unique T cell type. Their development relies on specific signaling pathways and interactions with CD1d-expressing cells in the thymus.

Area of Science:

  • Immunology
  • Cell Biology
  • Developmental Biology

Background:

  • Invariant natural killer T (Valpha14i NKT) cells bridge innate and adaptive immunity, exhibiting characteristics of both NK cells and T cells.
  • These cells utilize a semi-invariant T cell receptor (TCR) comprising a Valpha14-Jalpha18 chain, recognizing CD1d-presented glycolipids.

Purpose of the Study:

  • To elucidate the unique developmental pathway of Valpha14i NKT cells.
  • To identify key regulatory mechanisms governing Valpha14i NKT cell development.
  • To explore the role of CD1d-mediated signaling in Valpha14i NKT cell lineage commitment.

Main Methods:

  • Analysis of thymocyte development and Valpha14i NKT cell maturation.
  • Investigation of TCR rearrangement and CD1d-glycolipid interactions.

Related Experiment Videos

  • Assessment of signaling pathways including Fyn/SAP/SLAM, NFkappaB, T-bet, and IL-15.

    • Main Results:

    • Valpha14i NKT cell development is initiated in CD4+CD8+ thymocytes through interaction with CD1d-expressing cells.
    • Maturation involves upregulation of activation markers (e.g., CD44) and expression of NK-related molecules (e.g., NKI.1, Ly-49 receptors).
    • Specific signaling pathways (Fyn/SAP/SLAM, NFkappaB, T-bet, IL-15) critically regulate Valpha14i NKT cell development.

    Conclusions:

    • The development of Valpha14i NKT cells is distinct from conventional T cells, requiring unique signaling cues.
    • CD1d-restricted glycolipid recognition is essential for the positive selection and lineage commitment of Valpha14i NKT cells.
    • The developmental paradigm of Valpha14i NKT cells may inform the study of other unconventional T cell subsets.